AGP Executive Report
Last update: 5 hours agoCancer Vaccines: A personalized mRNA vaccine paired with Merck’s Keytruda cut melanoma recurrence or death risk by 42% versus Keytruda alone, fueling efforts to test the approach in other cancers. Weight-Loss Drugs: Lilly’s retatrutide outperformed Ozempic in a head-to-head type 2 diabetes trial for weight loss and blood sugar control. Stroke Response: On World Stroke Day, clinicians urged people to use the FAST signs—face drooping, arm weakness, speech trouble—to recognize a stroke and call emergency services immediately. Hospital Expansion: Fortis Healthcare completed its roughly Rs 277 crore acquisition of Bengaluru’s 110-bed Suguna Hospital, with scope to expand the site to 150 beds. Medicine Access: A report found uneven uptake of some new medicines across Scotland’s health boards, particularly GLP-1 drugs, pointing to possible avoidable barriers for patients. Drug Manufacturing: Ghana launched a policy to raise the share of locally made medicines from about 30% to 60% and reduce reliance on imports.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
